- Home
- POCI vs SRZN Comparison
POCI vs SRZN Comparison
Compare POCI & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POCI
- SRZN
- Stock Information
- Founded
- POCI 1982
- SRZN 2015
- Country
- POCI United States
- SRZN United States
- Employees
- POCI N/A
- SRZN N/A
- Industry
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- POCI Health Care
- SRZN Health Care
- Exchange
- POCI Nasdaq
- SRZN Nasdaq
- Market Cap
- POCI 32.4M
- SRZN 38.1M
- IPO Year
- POCI N/A
- SRZN N/A
- Fundamental
- Price
- POCI $4.89
- SRZN $12.08
- Analyst Decision
- POCI
- SRZN Strong Buy
- Analyst Count
- POCI 0
- SRZN 1
- Target Price
- POCI N/A
- SRZN $45.00
- AVG Volume (30 Days)
- POCI 11.0K
- SRZN 53.7K
- Earning Date
- POCI 02-12-2025
- SRZN 11-06-2024
- Dividend Yield
- POCI N/A
- SRZN N/A
- EPS Growth
- POCI N/A
- SRZN N/A
- EPS
- POCI N/A
- SRZN N/A
- Revenue
- POCI $18,980,148.00
- SRZN $10,000,000.00
- Revenue This Year
- POCI N/A
- SRZN N/A
- Revenue Next Year
- POCI N/A
- SRZN N/A
- P/E Ratio
- POCI N/A
- SRZN N/A
- Revenue Growth
- POCI N/A
- SRZN N/A
- 52 Week Low
- POCI $3.47
- SRZN $6.00
- 52 Week High
- POCI $6.90
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- POCI 48.33
- SRZN 50.51
- Support Level
- POCI $4.62
- SRZN $10.20
- Resistance Level
- POCI $5.30
- SRZN $12.51
- Average True Range (ATR)
- POCI 0.22
- SRZN 2.03
- MACD
- POCI -0.01
- SRZN -0.29
- Stochastic Oscillator
- POCI 39.71
- SRZN 24.91
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).